Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Andorn

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Brain Research|December 24, 1991
The low affinity component of [3H]clonidine binding is absent in the prefrontal cortex of presumptive suicide victimsA C Andorn
Life Sciences|April 7, 1986
Do antipsychotic drugs and serotonin down regulate [3H]-spiroperidol binding sites in human cortex?A C Andorn
Neurobiology of Aging|March 1, 1991
Adrenergic receptors in aging and Alzheimer's disease: decreased alpha 2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortexR N Kalaria, A C Andorn
Free Radical Biology & Medicine|July 20, 2001
Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brainA C Andorn, M A Pappolla
Journal of Neurochemistry|November 1, 1980
[3H]Spiroperidol binding in rat striatum: two high-affinity sites of differing selectivitiesA C Andorn, M E Maguire
European Journal of Pharmacology|August 3, 1984
Guanyl nucleotides decrease antagonist binding at high affinity dopamine receptorsA C Andorn, K R Kohagen
Synapse (New York, N.Y.)|January 1, 1987
Serum protein leakage in aged human brain and inhibition of ligand binding at alpha 2-adrenergic and cholinergic binding sitesM A Pappolla, A C Andorn
Human Pathology|April 1, 1986
Neuronal agingM A Pappolla, A C Andorn
European Journal of Pharmacology|April 9, 1986
[3H]clonidine binds at multiple high affinity states in human prefrontal cortexM A Carlson, A C Andorn
Progress in Clinical and Biological Research|January 1, 1989
Serum protein interactions with neurotransmitter receptors: implications for Alzheimer's diseaseA C Andorn, M A Pappolla
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Brain Research|December 24, 1991
The low affinity component of [3H]clonidine binding is absent in the prefrontal cortex of presumptive suicide victimsA C Andorn
Life Sciences|April 7, 1986
Do antipsychotic drugs and serotonin down regulate [3H]-spiroperidol binding sites in human cortex?A C Andorn
Neurobiology of Aging|March 1, 1991
Adrenergic receptors in aging and Alzheimer's disease: decreased alpha 2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortexR N Kalaria, A C Andorn
Free Radical Biology & Medicine|July 20, 2001
Catecholamines inhibit lipid peroxidation in young, aged, and Alzheimer's disease brainA C Andorn, M A Pappolla
Journal of Neurochemistry|November 1, 1980
[3H]Spiroperidol binding in rat striatum: two high-affinity sites of differing selectivitiesA C Andorn, M E Maguire
European Journal of Pharmacology|August 3, 1984
Guanyl nucleotides decrease antagonist binding at high affinity dopamine receptorsA C Andorn, K R Kohagen
Synapse (New York, N.Y.)|January 1, 1987
Serum protein leakage in aged human brain and inhibition of ligand binding at alpha 2-adrenergic and cholinergic binding sitesM A Pappolla, A C Andorn
Human Pathology|April 1, 1986
Neuronal agingM A Pappolla, A C Andorn
European Journal of Pharmacology|April 9, 1986
[3H]clonidine binds at multiple high affinity states in human prefrontal cortexM A Carlson, A C Andorn
Progress in Clinical and Biological Research|January 1, 1989
Serum protein interactions with neurotransmitter receptors: implications for Alzheimer's diseaseA C Andorn, M A Pappolla
Pageof 3